Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Return on Invested Capital (2020 - 2025)

Legend Biotech filings provide 6 years of Return on Invested Capital readings, the most recent being 0.11% for Q1 2025.

  • On a quarterly basis, Return on Invested Capital fell 24.0% to 0.11% in Q1 2025 year-over-year; TTM through Mar 2025 was 0.11%, a 24.0% decrease, with the full-year FY2024 number at 0.0%, down 145.0% from a year prior.
  • Return on Invested Capital hit 0.11% in Q1 2025 for Legend Biotech, up from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.4% in Q2 2024 to a low of 481.53% in Q2 2021.
  • Median Return on Invested Capital over the past 5 years was 0.0% (2022), compared with a mean of 34.41%.
  • Biggest five-year swings in Return on Invested Capital: soared 44bps in 2022 and later plummeted -32bps in 2024.
  • Legend Biotech's Return on Invested Capital stood at 0.24% in 2021, then skyrocketed by 102bps to 0.0% in 2022, then skyrocketed by 6731bps to 0.33% in 2023, then tumbled by -99bps to 0.0% in 2024, then soared by 3954bps to 0.11% in 2025.
  • The last three reported values for Return on Invested Capital were 0.11% (Q1 2025), 0.0% (Q4 2024), and 0.4% (Q3 2024) per Business Quant data.